J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 76 (1995), 2717-2722; DOI 10.1099/0022-1317-76-11-2717
© 1995 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakai, H.
Right arrow Articles by Adachi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakai, H.
Right arrow Articles by Adachi, A.
Agricola
Right arrow Articles by Sakai, H.
Right arrow Articles by Adachi, A.

Function of human immunodeficiency virus type 1 Vpu protein in various cell types

Hiroyuki Sakai, Kenzo Tokunaga, Meiko Kawamura and Akio Adachi*

Institute for Virus Research, Kyoto University, Sakyo-ku, Kyoto 606, Japan

We evaluated the function of human immunodeficiency virus type 1 vpu gene in various cell lines. We established a highly sensitive system consisting of chloramphenicol acetyltransferase and reverse transcriptase assays and used it to monitor the effects of mutation of the vpu gene. In some cell lines, Vpu protein was not required at the early phase of viral replication but was important for efficient virion production. In these cells, the Vpu protein functioned effectively irrespective of the presence of intact env gene products. Likewise, CD4 gene expression had no effects on Vpu function. In the other cell lines tested, Vpu protein was not important for virion release, and the vpu mutant clone generated a normal level of progeny virions upon transfection.

* Author for correspondence. Fax +81 75 751 3995. e-mail aadati@virusl.virus.kyoto-u.ac.jp

Received 20 March 1995; accepted 10 July 1995.


This article has been cited by other articles:


Home page
J. Virol.Home page
A. Salim and L. Ratner
Modulation of {beta}-Catenin and E-Cadherin Interaction by Vpu Increases Human Immunodeficiency Virus Type 1 Particle Release
J. Virol., April 15, 2008; 82(8): 3932 - 3938.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
K. H. Richards and P. R. Clapham
Effects of vpu start-codon mutations on human immunodeficiency virus type 1 replication in macrophages
J. Gen. Virol., October 1, 2007; 88(10): 2780 - 2792.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Munk, J. Zielonka, H. Constabel, B.-P. Kloke, B. Rengstl, M. Battenberg, F. Bonci, M. Pistello, M. Lochelt, and K. Cichutek
Multiple Restrictions of Human Immunodeficiency Virus Type 1 in Feline Cells
J. Virol., July 1, 2007; 81(13): 7048 - 7060.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. Noble, P. Abada, J. Nunez-Iglesias, and P. M. Cannon
Recruitment of the Adaptor Protein 2 Complex by the Human Immunodeficiency Virus Type 2 Envelope Protein Is Necessary for High Levels of Virus Release
J. Virol., March 15, 2006; 80(6): 2924 - 2932.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Abada, B. Noble, and P. M. Cannon
Functional Domains within the Human Immunodeficiency Virus Type 2 Envelope Protein Required To Enhance Virus Production
J. Virol., March 15, 2005; 79(6): 3627 - 3638.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
G. D. Ewart, N. Nasr, H. Naif, G. B. Cox, A. L. Cunningham, and P. W. Gage
Potential New Anti-Human Immunodeficiency Virus Type 1 Compounds Depress Virus Replication in Cultured Human Macrophages
Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2325 - 2330.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. Varthakavi, R. M. Smith, S. P. Bour, K. Strebel, and P. Spearman
Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production
PNAS, December 9, 2003; 100(25): 15154 - 15159.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Deora and L. Ratner
Viral Protein U (Vpu)-Mediated Enhancement of Human Immunodeficiency Virus Type 1 Particle Release Depends on the Rate of Cellular Proliferation
J. Virol., July 15, 2001; 75(14): 6714 - 6718.
[Abstract] [Full Text]


Home page
J. Virol.Home page
M. Gasmi, J. Glynn, M.-J. Jin, D. J. Jolly, J.-K. Yee, and S.-T. Chen
Requirements for Efficient Production and Transduction of Human Immunodeficiency Virus Type 1-Based Vectors
J. Virol., March 1, 1999; 73(3): 1828 - 1834.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1995 by the Society for General Microbiology.